Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 27 resultados

RESPIRE-EXCEL: Respiratory Precision Medicine PhD Training Network Excellence through Systems Biology Spatial and... EUROPEAN RESPIRATORY SOCIETY participó en un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 Asthma and COPD are prevalent, chronic respiratory diseases, with high incidence and societal costs. Current treatment is based on a ‘one-si...
2024-07-01 - 2029-02-28 | Financiado

EU PAL-COPD: Evaluation of the ICLEAR-EU intervention to integrate palliative care in the treatment of people wit... EUROPEAN RESPIRATORY SOCIETY participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Chronic Obstructive Pulmonary Disease (COPD) is a devastating life-limiting lung disease with a high personal and societal burden. Worldwide...
2023-12-08 - 2028-12-31 | Financiado

IDERHA: Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance EUROPEAN RESPIRATORY SOCIETY participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage IDERHA will address the key obstacles to achieving appropriate access, sharing, use and reuse of lung cancer data, and thus enable enhanced...
2023-05-10 - 2028-03-31 | Financiado

OPTIMA: Optimal treatment for patients with solid tumours in Europe through Artificial intelligence EUROPEAN RESPIRATORY SOCIETY participó en un H2020: H2020-JTI-IMI2-2020-23-two-stage OPTIMA is a multi-stakeholder-led consortium with the vision that each and every patient should have access to the most up-to-date individua...
2021-10-18 - 2026-09-30 | Financiado

UNITE4TB: ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS EUROPEAN RESPIRATORY SOCIETY participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage Current anti-tuberculosis (TB) drug regimens face serious limitations at times of increasing antimicrobial drug resistance. Fortunately, for...
2021-06-29 - 2028-05-31 | Financiado

ECRAID-Base: European Clinical Research Alliance on Infectious Diseases EUROPEAN RESPIRATORY SOCIETY participó en un H2020: H2020-SC1-BHC-2018-2020 ECRAID-Base (European Clinical Research Alliance for Infectious Diseases) continues the activities of PREPARE, COMBACTE and ECRAID-Plan, whi...
2021-01-29 - 2026-02-28 | Financiado

DRAGON: The RapiD and SecuRe AI enhAnced DiaGnosis Precision Medicine and Patient EmpOwerment Centered Deci... EUROPEAN RESPIRATORY SOCIETY participó en un H2020: H2020-JTI-IMI2-2020-21-single-stage In this project, a multinational consortium of high-tech SMEs, academic research institutes, biotech and pharma partners, affiliated patient...
2020-10-22 - 2024-03-31 | Financiado

discovAIR: Discovering the cellular landscape of the airways and the lung EUROPEAN RESPIRATORY SOCIETY participó en un H2020: H2020-SC1-BHC-2018-2020 Lung diseases are a leading cause of death, with increasing incidence and lack of curative interventions. The development of novel therapeut...
2019-12-09 - 2022-06-30 | Financiado

FAIR: FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG RESISTA... EUROPEAN RESPIRATORY SOCIETY participó en un H2020: H2020-SC1-BHC-2018-2020 Bacterial pneumonia is a leading cause of morbidity and mortality worldwide. Antibiotics constitute the standard of care but are faced with...
2019-12-06 - 2025-06-30 | Financiado

3TR: Identification of the Molecular Mechanisms of non response to Treatments Relapses and Remission in... EUROPEAN RESPIRATORY SOCIETY participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage 3TR is a transdisciplinary consortium made of experts in all areas of medicine, basic sciences and bioinformatics from academic institutions...
2019-08-22 - 2026-08-31 | Financiado

RESPIRE4: REspiratory Science Promoted by International Research Exchanges 4 EUROPEAN RESPIRATORY SOCIETY tramitó un H2020: H2020-MSCA-COFUND-2018 The European Respiratory Society (ERS) is the largest society of lung clinicians and scientists in Europe, with a growing international memb...
2019-04-11 - 2026-09-30 | Financiado

VALUE-Dx: The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use Antimicrobial resistance (AMR) is of great public health concern, causing numerous losses of lives worldwide and threatening to reverse many...
2019-03-25 - 2024-09-30 | Financiado

BETTER-B: BETTER TREATMENTS FOR BREATHLESSNESS IN PALLIATIVE AND END OF LIFE CARE EUROPEAN RESPIRATORY SOCIETY participó en un H2020: H2020-SC1-BHC-2018-2020 The BETTER-B consortium tests whether mirtazapine, currently used as an antidepressant, is an effective treatment to reduce chronic or refra...
2018-12-03 - 2023-12-31 | Financiado

EUREST-PLUS: European Regulatory Science on Tobacco Policy implementation to reduce lung diseases EUROPEAN RESPIRATORY SOCIETY participó en un H2020: H2020-HCO-2014-2015 Smoking and other forms of tobacco consumption are considered the single most important cause of preventable morbidity and premature mortali...
2016-04-06 - 2018-12-31 | Financiado

RESPIRE 3: REspiratory Science Promoted by International Research Exchanges 3 EUROPEAN RESPIRATORY SOCIETY tramitó un H2020: H2020-MSCA-COFUND-2015 The European Respiratory Society (ERS) is the main scientific society in the respiratory field in Europe. ERS mission is to promote lung hea...
2016-03-09 - 2022-02-28 | Financiado

PRO- ACTIVE: Physical Activity as a Crucial Patient Reported Outcome in COPD EUROPEAN RESPIRATORY SOCIETY participó en un FP6: Physical activity (PA) is essential in maintaining optimal health in chronic diseases, including COPD.More physically active patients have l...
2009-09-01 - 2016-05-31 | Financiado

RESPIRE 2: REspiratory Science Promoted by International Research Exchanges 2 EUROPEAN RESPIRATORY SOCIETY tramitó un FP7: "The ERS, the main scientific society in the respiratory field in Europe, promotes research into respiratory diseases in children and adults...
Financiado

RESPIRE: Respiratory Science Promoted by International Research Exchanges EUROPEAN RESPIRATORY SOCIETY tramitó un FP7: The European Respiratory Society (ERS), the main scientific society in the respiratory field in Europe, promotes research into respiratory d...
Financiado